NORTH AMERICAN SCIENTIFIC INC
10-Q, EX-27, 2000-08-31
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NORTH AMERICAN SCIENTIFIC INC, 10-Q, 2000-08-31
Next: ECHOCATH INC, DEF 14A, 2000-08-31



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-START>                             NOV-01-1999
<PERIOD-END>                               JUL-31-2000
<CASH>                                       3,353,000
<SECURITIES>                                 8,142,000
<RECEIVABLES>                                1,248,000
<ALLOWANCES>                                  (36,000)
<INVENTORY>                                    827,000
<CURRENT-ASSETS>                            14,493,000
<PP&E>                                       4,926,000
<DEPRECIATION>                             (1,326,000)
<TOTAL-ASSETS>                              28,537,000
<CURRENT-LIABILITIES>                        1,461,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        69,000
<OTHER-SE>                                  26,893,000
<TOTAL-LIABILITY-AND-EQUITY>                28,537,000
<SALES>                                      4,450,000
<TOTAL-REVENUES>                             4,450,000
<CGS>                                        1,478,000
<TOTAL-COSTS>                                  885,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              2,364,000
<INCOME-TAX>                                   884,000
<INCOME-CONTINUING>                          1,480,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,480,000
<EPS-BASIC>                                       0.21
<EPS-DILUTED>                                     0.20


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission